Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Indlægsklinikken.dk ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   4.9% 5.3% 4.9% 4.2% 2.9% 4.2% 14.1% 14.1%   Credit score (0-100)   45 42 43 48 58 49 16 16   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,619 1,626 1,883 2,689 2,333 2,868 0.0 0.0   EBITDA   353 347 496 658 332 253 0.0 0.0   EBIT   308 288 412 560 237 205 0.0 0.0   Pre-tax profit (PTP)   305.5 280.6 408.0 557.4 233.8 204.8 0.0 0.0   Net earnings   236.3 214.6 320.4 434.6 184.4 161.2 0.0 0.0   Pre-tax profit without non-rec. items   305 281 408 557 234 205 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   246 202 289 191 96.1 90.9 0.0 0.0   Shareholders equity total   464 428 549 863 614 591 304 304   Interest-bearing liabilities   1.0 1.0 1.0 1.0 187 0.0 0.0 0.0   Balance sheet total (assets)   930 1,186 1,238 1,631 1,585 1,278 304 304   Net Debt   -213 -510 -305 -562 -350 -542 -304 -304     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,619 1,626 1,883 2,689 2,333 2,868 0.0 0.0   Gross profit growth   74.0% 0.4% 15.8% 42.8% -13.2% 22.9% -100.0% 0.0%   Employees   0 2 2 3 4 5 0 0   Employee growth %   0.0% 0.0% 0.0% 50.0% 33.3% 25.0% -100.0% 0.0%   Employee expenses   -1,258.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   930 1,186 1,238 1,631 1,585 1,278 304 304   Balance sheet change%   32.9% 27.5% 4.4% 31.7% -2.8% -19.3% -76.2% 0.0%   Added value   1,612.0 347.4 495.6 657.6 334.8 253.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   173 -104 4 -196 -190 -54 -91 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.0% 17.7% 21.9% 20.8% 10.2% 7.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   37.8% 27.2% 34.0% 39.0% 14.7% 14.3% 0.0% 0.0%   ROI %   72.0% 63.7% 83.1% 78.8% 28.5% 29.5% 0.0% 0.0%   ROE %   59.0% 48.1% 65.6% 61.6% 25.0% 26.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   49.8% 36.1% 44.3% 52.9% 38.7% 46.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -60.2% -146.8% -61.5% -85.5% -105.5% -214.0% 0.0% 0.0%   Gearing %   0.2% 0.2% 0.2% 0.1% 30.5% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.5% 699.3% 404.6% 233.3% 3.4% 0.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.2 1.0 0.6 1.0 0.7 1.0 0.0 0.0   Current Ratio   1.4 1.3 1.2 1.9 1.4 1.5 0.0 0.0   Cash and cash equivalent   213.5 511.1 306.0 563.5 537.6 542.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   168.3 171.5 139.7 579.5 352.0 311.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 174 248 219 84 51 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 174 248 219 83 51 0 0   EBIT / employee   0 144 206 187 59 41 0 0   Net earnings / employee   0 107 160 145 46 32 0 0